Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate U.S. Clinical Trial Preparations for CLD-001 TOKYO, Oct. 4, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO: Nobuyuki Arakawa; "Celaid") today announced the...
Hence then, the article about celaid therapeutics completes second close of series b financing round was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Celaid Therapeutics Completes Second Close of Series B Financing Round )
Also on site :
- ‘Grey’s Anatomy’ Star Receives Outpouring of Support After Revealing Wife Died From Massive Hemorrhagic Stroke
- Macron laments the EU’s nosedive like he’s not one of the pilots
- Box Office: ‘Digger’ Majorly Bombs With $8 Million Opening Weekend, ‘Verity’ Scores $32 Million Debut